Rodanthi Vyzoukaki
Irakleion, ESYE43, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Serum Levels of Soluble FLT3 Ligand in Patients with Active Multiple Myeloma Constitute Marker of Bone Marrow Plasma Cell Proliferative Activity.
Journal: Critical reviews in oncogenesis
Published: January 01, 2017
Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple Myeloma.
Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple Myeloma.
Journal: Clinical therapeutics
Published: September 01, 2015
The Impact of Mast Cell Density on the Progression of Bone Disease in Multiple Myeloma Patients.
Journal: International archives of allergy and immunology
Published: September 01, 2015
Potential role of FLT3-ligand in the angiogenic process of multiple myeloma.
Journal: Leukemia research
Published: July 06, 2015
Activated Protein C-Resistance Determination and Vascular Access Thrombosis in Populations with High Prevalence of Factor V Leiden.
Journal: Nephron
Published: February 20, 2015
High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activity.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: January 21, 2015
Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity.
Journal: Medical oncology (Northwood, London, England)
Published: December 23, 2014
Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma.
Journal: Journal of cancer research and clinical oncology
Published: November 10, 2014
Circulating levels of soluble Fas ligand reflect disease progression in multiple myeloma.
Journal: Medical oncology (Northwood, London, England)
Published: March 10, 2014
Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-α in multiple myeloma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: November 26, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026